Apoptotic protein profile in Leishmania donovani after treatment with hexaazatrinaphthylenes derivatives.
Exp Parasitol
; 166: 83-8, 2016 Jul.
Article
en En
| MEDLINE
| ID: mdl-27060614
ABSTRACT
Two hexaazatrinaphthylene derivatives, DGV-B and DGV-C previously known to induce an apoptotic-like process in Leishmania donovani parasites were used in this study. For this purpose, two different human protein commercial arrays were used to determine the proteomic profile of the treated parasites compared to non-treated ones. One of the commercial arrays is able to detect the relative expression of 35 human apoptosis-related proteins and the other one is able to identify 9 different human kinases. The obtained results showed that the two tested molecules were able to activate a programmed cell death process by different pathways in the promastigote stage of the parasite. The present study reports the potential application of two commercialised human apoptotic arrays to evaluate the action mechanism of active compounds at least against Leishmania donovani. The obtained data would be useful to establish the putative activated apoptosis pathways in the treated parasites and to further support the use of hexaazatrinaphthylene derivatives for the treatment of leishmaniasis in the near future. Nevertheless, further molecular studies should be developed in order to design and evaluate specific apoptotic arrays for Leishmania genus.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Leishmania donovani
/
Proteínas Protozoarias
/
Apoptosis
/
Proteoma
/
Naftalenos
Límite:
Humans
Idioma:
En
Revista:
Exp Parasitol
Año:
2016
Tipo del documento:
Article